General Information of Drug Transporter (DT)
DT ID DTD0175 Transporter Info
Gene Name SLC25A16
Transporter Name Graves disease carrier protein
Gene ID
8034
UniProt ID
P16260
Post-Translational Modification of This DT
Overview of SLC25A16 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Malonylation X-O-glycosylation X-Oxidation X-Phosphorylation X: Amino Acid

Malonylation

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A16 [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

51

Experimental Method

Co-Immunoprecipitation

Detailed Description

Malonylation at SLC25A16 Lysine 51 has the potential to affect its expression or activity.

O-glycosylation

  Serine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A16 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

206

Experimental Method

Co-Immunoprecipitation

Detailed Description

O-linked Glycosylation at SLC25A16 Serine 206 has the potential to affect its expression or activity.

  Threonine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A16 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

123

Experimental Method

Co-Immunoprecipitation

Detailed Description

O-linked Glycosylation at SLC25A16 Threonine 123 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A16 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

195

Experimental Method

Co-Immunoprecipitation

Detailed Description

O-linked Glycosylation at SLC25A16 Threonine 195 has the potential to affect its expression or activity.

Oxidation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A16 [3]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

311

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC25A16 Cystine 311 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A16 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

78

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A16 Serine 78 has the potential to affect its expression or activity.

  Threonine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A16 [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

5

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A16 Threonine 5 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC25A16 [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

29

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A16 Threonine 29 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC25A16 [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

30

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A16 Threonine 30 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC25A16 [7]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

289

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC25A16 Tyrosine 289 has the potential to affect its expression or activity.
References
1 Proteomic and Biochemical Studies of Lysine Malonylation Suggest Its Malonic Aciduria-associated Regulatory Role in Mitochondrial Function and Fatty Acid Oxidation. Mol Cell Proteomics. 2015 Nov;14(11):3056-71.
2 Mapping and Quantification of Over 2000 O-linked Glycopeptides in Activated Human T Cells with Isotope-Targeted Glycoproteomics (Isotag). Mol Cell Proteomics. 2018 Apr;17(4):764-775.
3 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
4 Quantitative phosphoproteomic analysis of acquired cancer drug resistance to pazopanib and dasatinib. J Proteomics. 2018 Jan 6;170:130-140.
5 HOPE-fixation of lung tissue allows retrospective proteome and phosphoproteome studies. J Proteome Res. 2014 Nov 7;13(11):5230-9.
6 Kinase activity ranking using phosphoproteomics data (KARP) quantifies the contribution of protein kinases to the regulation of cell viability. Mol Cell Proteomics. 2017 Sep;16(9):1694-1704.
7 A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.